Gisselsson David, Pirnay Jean-Paul, Wiederoder Michael, Hart Corey, Rinaldi Alberto, Gorgé Olivier, Iriye Heather, Carvalho Luís, Sedlackova Lucie, Voie Øyvind, Robinson Yohan
Exploratory Team 221, Human Factors and Medicine, NATO Science and Technology Organization; Lund University Center for Preparedness and Resilience, Lund University, Sweden; Division of Clinical Genetics, Faculty of Medicine, Lund University, Sweden.
Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, Belgium.
Biotechnol Adv. 2025 Nov;84:108695. doi: 10.1016/j.biotechadv.2025.108695. Epub 2025 Aug 25.
Biotechnology is a rapidly progressive field, currently transforming agriculture, healthcare, and life sciences. This rapid development comes with serious legal and ethical challenges as well as risks for human security and health. NATO has prioritized biotechnology and human enhancement technologies for defense, focusing on legitimate, defensive applications. This paper highlights four clusters of biomedical technologies with the potential to enhance warfighter performance: These technologies, progressing in civilian sectors, have significant potential to enhance military capabilities in the near future (5-10 years). Oversight and prioritization of human rights are essential to ensure responsible application, maintaining human dignity, bodily integrity, and personal autonomy even in wartime. As military innovation systems worldwide are advancing in strategic biotechnologies, it is critical for NATO countries to maintain synergistic intra-alliance collaboration in this intense field.
生物技术是一个快速发展的领域，目前正在改变农业、医疗保健和生命科学。这种快速发展带来了严峻的法律和伦理挑战，以及对人类安全与健康的风险。北约已将生物技术和人类增强技术作为国防重点，专注于合法的防御性应用。本文重点介绍了四类有可能提升作战人员性能的生物医学技术：这些技术在民用领域不断发展，在不久的将来（5至10年）具有显著提升军事能力的潜力。对人权进行监督和确定优先事项对于确保负责任的应用至关重要，即使在战时也要维护人的尊严、身体完整性和个人自主权。随着全球军事创新系统在战略生物技术方面不断推进，北约国家在这一激烈领域保持联盟内部的协同合作至关重要。
